Advisory Services Network’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
ISL
VPM
VCM
PA
Advisory Services Network's CORT Position: Q1 2026 in Review
Advisory Services Network opened a new position in Corcept Therapeutics (CORT) in Q1 2026: 739 shares worth $29.8K. The stake represents ﹤0.01% of the portfolio and ranks #2955 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CORT as recently as Q3 2025.
Advisory Services Network first reported a position in CORT in Q1 2018 and has held it in 17 quarters since. The position peaked at $803K in Q1 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.
- Advisory Services Network held 739 shares of Corcept Therapeutics worth $29.8K as of Q1 2026.
- Corcept Therapeutics was a new Advisory Services Network position in Q1 2026.
- Corcept Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2955 holding.
- Advisory Services Network first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 17 quarters since.
- Advisory Services Network's Corcept Therapeutics position peaked at $803K in Q1 2025.
- 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.